Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib has common side effects like headache and acne, and unexpected ones like diabetes and thyroid issues.

Combining TCA with 5-FU is more effective and safer for treating keloids than TCA alone.

Patients with the same genetic mutation for vitamin D-resistant rickets showed different symptoms but all improved with treatment except for hair loss.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Onabotulinum toxin A may help treat trichotillomania and promote hair growth.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Gemcitabine and paclitaxel are effective and safe as first-line treatment for metastatic breast cancer.

Intravenous arsenic is safe and effective for treating certain blood cancers.

Voglibose may help treat skin hyperpigmentation safely.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Adverse events from vismodegib can be managed effectively to ensure optimal treatment.

Topical tacrolimus is effective and safe for treating alopecia areata.

The new drug delivery system effectively targets lung cancer cells.

Vitamin D3 is a safe and effective alternative to steroids for treating alopecia areata, with fewer side effects.

Baricitinib is effective as a treatment for severe hair loss.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Toluidine blue helps accurately diagnose and treat certain skin tumors in surgery.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Bicalutamide may be a promising alternative treatment for female pattern hair loss.

ROR-alpha may increase the growth of certain breast cancer cells by boosting aromatase, which could affect breast cancer prognosis.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Megavoltage radiation therapy extended survival in rabbits with thymomas, especially in those weighing more than 1.57 kg.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.